Growth Hormone Deficiency (GHD) is a medical condition resulting from insufficient secretion of growth hormone (GH) by the anterior pituitary gland. Distinct clinical features and a spectrum of genetic and acquired causes impacting paediatric and adult populations characterize GHD. Combined Pituitary Hormone Deficiency (CPHD) is a disorder related to GHD, and it is characterized by insufficient production of multiple pituitary hormones, including GH, often leading to more complex clinical management compared to isolated GHD. GHD is a rare disease, and it urges prompt evaluation and treatment. On the contrary, Congenital Delay of Growth and Puberty (CDGP) is a benign condition. Treatment in this situation is seldom performed to trigger normal and autonomous growth. Nevertheless, the differential diagnosis between GHD and CDGP poses a considerable problem to the paediatric endocrinologist. The 2025 Learning Journey in Growth Disorders: from Global to Local aim is to provide participants with best practices and latest evidence-supported approach for growth hormone disorders management. The Live Webinar covers the fundamentals of GHD diagnosis and treatment, while the in the Interactive Talk-Show with the participation of an experts’ panel dives into more complex cases, acquired conditions, and combined hormonal therapies. Attending both ensures a full understanding of growth disorders from diagnosis to long-term management.
Cappa Marco
